Bitter Ironies Confound Career Hopes Of Today's Young Researchers

Confidence and ambition, however, are ceding to worry and resignation. We see increasing numbers of our comrades getting stuck in perpetual postdoctoral appointments while they apply over and over for rare faculty jobs. Even if one attains a cherished tenure-track position, the chances of earning a competitive research grant have seldom been worse. The situation is clearly discouraging, since fewer and fewer biomedical faculty under

Written byMark Paalman
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Confidence and ambition, however, are ceding to worry and resignation. We see increasing numbers of our comrades getting stuck in perpetual postdoctoral appointments while they apply over and over for rare faculty jobs. Even if one attains a cherished tenure-track position, the chances of earning a competitive research grant have seldom been worse. The situation is clearly discouraging, since fewer and fewer biomedical faculty under age 37 are applying for life-blood National Institutes of Health research grants. And on the industrial side, layoffs and forced retirements by the likes of IBM and Dow Chemical parallel those in the defense industry and lead young scientists to wonder if there are any stable career choices left.

Whether doctoral candidates or postdoctoral fellows, with designs on industry or academe, we--the fledgling researchers of the wealthiest country on Earth--are now struggling with grim prospects for gainful employment in the near future. We must look ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies